Mutual Of America Capital Management LLC Esperion Therapeutics, Inc. Transaction History

Mutual Of America Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$11.34 - $21.37 $835,327 - $1.57 Million	-73,662 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$19.4 - $28.71 $61,478 - $90,981	-3,169 Reduced 4.12%	73,662 $1.56 Million
Q1 2021 May 13, 2021	SELL	$25.12 - $36.89 $106,810 - $156,856	-4,252 Reduced 5.24%	76,831 $2.16 Million
Q4 2020 Feb 12, 2021	SELL	$24.2 - $35.76 $41,309 - $61,042	-1,707 Reduced 2.06%	81,083 $2.11 Million
Q3 2020 Nov 13, 2020	BUY	$31.18 - $52.71 $830,635 - $1.4 Million	26,640 Added 47.44%	82,790 $3.08 Million
Q2 2020 Aug 06, 2020	BUY	$30.04 - $51.31 $718,857 - $1.23 Million	23,930 Added 74.27%	56,150 $2.88 Million
Q1 2020 May 11, 2020	BUY	$27.44 - $73.84 $884,116 - $2.38 Million	32,220 New	32,220 $1.02 Million

209

129M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $125M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.